Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1989-6-30
|
pubmed:abstractText |
A 40-year-old woman, who had previously received radioactive iodine for hyperthyroidism, presumably due to Graves' disease, subsequently was found to have inappropriately elevated serum TSH and alpha-subunit levels and a pituitary adenoma. Detailed clinical studies revealed marked serum TSH elevations (approximately 100 mU/L) with no circadian variation, but with 7 pulses/24 h. Serum alpha-subunit levels averaged 2.5 micrograms/L, with 13 pulses/24 h. Neither serum TSH nor alpha-subunit responded to TRH stimulation, nor did serum TSH change during dopamine infusion, but alpha-subunit levels did decline slightly. In contrast, during somatostatin infusion, serum TSH declined to 30% of baseline levels, while alpha-subunit levels did not change. Pituitary adenoma tissue obtained at the time of transsphenoidal surgery immunostained weakly with anti-TSH beta serum and strongly with anti-alpha-subunit serum. Northern blot analysis of RNA isolated from the tumor revealed TSH beta and alpha-subunit mRNA levels of normal length, while primer extension analysis showed a major initiation site for the TSH beta gene that appeared to be identical in the tumor and normal pituitary tissue. A second minor upstream start site was detected in the tumor, but it represented less than 1% of transcription compared to the major downstream start site. We conclude that the tumor secreted TSH and alpha-subunit in an abnormal and discordant fashion, but that the TSH gene initiation site appeared to be normal and, therefore, did not explain the observed secretory abnormalities.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0021-972X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1211-5
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2723029-Adenoma,
pubmed-meshheading:2723029-Adult,
pubmed-meshheading:2723029-Autoradiography,
pubmed-meshheading:2723029-Female,
pubmed-meshheading:2723029-Gene Expression Regulation,
pubmed-meshheading:2723029-Histocytochemistry,
pubmed-meshheading:2723029-Humans,
pubmed-meshheading:2723029-Hyperthyroidism,
pubmed-meshheading:2723029-Immunochemistry,
pubmed-meshheading:2723029-Pituitary Neoplasms,
pubmed-meshheading:2723029-RNA, Messenger,
pubmed-meshheading:2723029-Thyrotropin,
pubmed-meshheading:2723029-Transcription, Genetic
|
pubmed:year |
1989
|
pubmed:articleTitle |
Clinical and molecular studies of a thyrotropin-secreting pituitary adenoma.
|
pubmed:affiliation |
Department of Medicine (Endocrinology), University of Colorado Health Sciences Center, Denver 80262.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.,
Case Reports
|